Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$99.12 USD
-1.84 (-1.82%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $99.08 -0.04 (-0.04%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth B Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ZBH 99.12 -1.84(-1.82%)
Will ZBH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ZBH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZBH
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
ZBH or ESLOY: Which Is the Better Value Stock Right Now?
ZBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
Other News for ZBH
How To YieldBoost Zimmer Biomet Holdings To 7.7% Using Options
ZBH Fell Below 200 Day Moving Average on September 15
Insider Sell: Sang Yi Sells 1,200 Shares of Zimmer Biomet Holdings Inc (ZBH)
Notable Two Hundred Day Moving Average Cross - ZBH
Is ZBH building bullish momentum? Non-ADX 1,2,3,4 Bullish shows up after dropping 1.13%